CVS Health Corporation
CVSHealthcareNASDAQHealthcare Plans
Scan Results
Daily timeframeCVS Health Corporation provides health solutions in the United States. The company carries a $122.87B market cap, placing it firmly in the large-cap category. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Market Cap
$122.87B
Beta
0.58
P/E (TTM)
25.35
P/E (Fwd)
11.29
EPS (TTM)
$3.79
EPS (Fwd)
$8.51
ROE
6.2%
ROA
3.0%
Cash
$13.96B
Total Debt
$76.31B
Free CF
$8.08B
52W Change
30.8%
Annual Financials
Cash vs Debt
Where CVS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CVS finished 10.26% above its 150-day moving average ($88.18) and 13.83% above its 200-day moving average ($85.42). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CVS overbought or oversold?
At the September 3, 2026 close, CVS's RSI(14) was 56.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $13.96B in cash, though total debt stands at $76.31B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $8.08B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 6.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $322.47B (2022) to $402.07B (2025), reflecting a 25% increase over the period.
The relatively low beta of 0.58 suggests CVS is a less volatile holding compared to the broader index. CVS Health Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing CVS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.